IDXG

Interpace Biosciences, Inc. Common Stock
IDXG

Overview Fund Activity
Delisted

IDXG was delisted on the 24th of February, 2021.

Back to rankings

28 hedge funds and large institutions have $32.9M invested in Interpace Biosciences, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
KCM
Kennedy Capital Management
Missouri
+$61.8K
2
HA
Heartland Advisors
Wisconsin
+$57.8K
3
Renaissance Technologies
Renaissance Technologies
New York
+$22.8K
4
MA
Minerva Advisors
Pennsylvania
+$14.5K
5
U
UBS
Switzerland
+$7.16K

Top Sellers

1
RA
Royce & Associates
New York
-$326K
2
SKK
Shepherd Kaplan Krochuk
Massachusetts
-$69.7K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$59K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$38.5K
5
TRCT
Tower Research Capital (TRC)
New York
-$10K
Name Holding Trade Value Shares
Change 		Shares
Change %
GSC
26
Ground Swell Capital
South Carolina
$2K +$2K +4 New
TRCT
27
Tower Research Capital (TRC)
New York
$1K -$10K -20 -91%
BNP Paribas Financial Markets
28
BNP Paribas Financial Markets
France
$31 -$33 – –
Jacobs Levy Equity Management
29
Jacobs Levy Equity Management
New Jersey
– -$59K -129 Closed
1
2